Search

Displaying results 8911 - 8920 of 10000 in total
  1. Drug

    ABBV-706

    go.drugbank.com/drugs/DB18710
    Investigational

    ABBV-706 is an antibody-drug conjugate that is anti-SEZ6.[L49156,L49161]

  2. Drug

    Novolimus

    go.drugbank.com/drugs/DB19085
    Investigational

    Novolimus is under investigation in clinical trial NCT04483791 (Dynamx Bioadaptor Hong Kong Registry).

  3. Drug

    Formononetin

    go.drugbank.com/drugs/DB15335
    Experimental

    Formononetin is under investigation in clinical trial NCT02174666 (Isoflavone Treatment for Postmenopausal Osteopenia.).

  4. Drug

    H-151

    go.drugbank.com/drugs/DB29149
    Experimental

    H-151 is an inhibitor of the stimulator of interferon genes (STING) protein.

    Synonyms: N-(4-ethylphenyl)-N'-1H-indol-3-yl-urea
  5. Drug

    Radafaxine

    go.drugbank.com/drugs/DB11790
    Investigational

    Radafaxine has been used in trials studying the treatment of Depressive Disorder, Major.

  6. Drug

    Henagliflozin

    go.drugbank.com/drugs/DB11939
    Investigational

    Henagliflozin has been used in trials studying the treatment of Type 2 Diabetes.

  7. Drug

    Bunazosin

    go.drugbank.com/drugs/DB12230
    Investigational

    Bunazosin has been used in trials studying the treatment of High Blood Pressure.

  8. Drug

    Octenidine

    go.drugbank.com/drugs/DB12624
    Investigational

    Octenidine is under investigation in clinical trial NCT02697162 (Antiseptic-coated Intermittent Urinary Catheter).

    Products: Octenimed 1 mg/ml Lösung zur Anwendung in der Mundhöhle, octenidin schülke 1 mg/ml Lösung zur Anwendung in der Mundhöhle
  9. Drug

    AZD-9684

    go.drugbank.com/drugs/DB05712
    Experimental

    AZD-9684 is the first member of a new anti-thrombotic class (CPU inhibitors). It is being developed by AstraZeneca.

  10. Drug

    Strontium malonate

    go.drugbank.com/drugs/DB05732
    Investigational

    Strontium malonate is being developed as a novel orally available pharmaceutical for the treatment and prevention of osteoporosis. It is being developed by Osteologix Inc.